A Comprehensive Review of Hedyotis Diffusa Willd–Scutellaria Barbata D. Don Herb Pair in Anti-Hepatocellular Carcinoma Effects - Review

Sep 22, 2026

Upload by Mabel

Hepatocellular carcinoma (HCC) is highlighted as a highly prevalent digestive-system malignancy with a rising global incidence. The review focuses on the traditional Chinese medicine (TCM) herb pair Hedyotis diffusa Willd and Scutellaria barbata D. Don, described as clearing heat and detoxifying, and widely used for HCC. Beyond evidence that individual herbs modulate apoptosis, proliferation, angiogenesis, and immune responses, the review emphasizes stronger effects from combined or newly generated components, synthesizing compatibility principles, pharmacological actions, and signaling mechanisms to support rational clinical use and further translational research.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages16

Reading Time40 min

AccessFree to download

Introduction

Background on primary hepatic cancer and HCC

Clinical treatments and limitations

TCM concepts and therapeutic principles

Herb pair overview

Definition and clinical rationale of herbal pairs

Roles of Hedyotis diffusa and Scutellaria barbata

Drug Design, Development and Therapy Open Access Full Text Article REVIEW A Comprehensive Review of Hedyotis Diffusa Willd–Scutellaria Barbata D. Don Herb Pair in Anti- Hepatocellular Carcinoma Effects and Their Combinatorial Effects and Mechanisms Ya Xu 1–3 , Weijia Xiang 1–3 , Wanyi Zhu 1–3 , Lanqi Shang 1–3 , Mengting Lun 1–3 , Songyan Qu 1–3 , Yizhen Yin 1–3 , Changrong Chen4 , Honggang Yuan 5 , Yinhong Song 1–3 1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China; 2Institution of Infection and Inflammation, China Three Gorges University, Yichang, People’s Republic of China; 3College of Basic Medical Sciences, China Three Gorges University, Yichang, People’s Republic of China; 4Department of Clinical Laboratory, Affiliated Renhe Hospital of China Three Gorges University, Yichang, People’s Republic of China; 5Department of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, People’s Republic of China Correspondence: Yinhong Song, Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, 443000, People’s Republic of China, Email [syh728@ctgu.edu.cn](syh728@ctgu.edu.cn); Honggang Yuan, Department of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443000, People’s Republic of China, Email [2820252006@qq.com](2820252006@qq.com) | Abstract: Hepatocellular carcinoma (HCC) is among the most prevalent malignancies of the digestive system, with a global rising incidence. Hedyotis diffusa Willd and Scutellaria barbata D. Don are classic herb pair in traditional Chinese medicine (TCM) of clearing heat and detoxifying, and is widely applied in the treatment of HCC. Although existing research has confirmed their efficacy against HCC through modulation of apoptosis, proliferation, angiogenesis, and immune responses, it is noteworthy that the combined or newly generated components after the compatibility of the two herbs exhibit even more pronounced therapeutic effects. In order to verify the pharmacological activity of the combination of Hedyotis diffusa Willd and Scutellaria barbata D. Don, it is necessary to try more in vitro and in vivo models. This review synthesizes current evidence on their TCM compatibility principles, pharmacological actions, and related signaling pathways of this herb pair, providing a rigorous theoretical foundation to guide rational clinical application and further translational research on the compatibility mechanism of the Hedyotis diffusa Willd–Scutellaria barbata D. Don herb pair in the treatment of HCC.
Keywords: Hedyotis diffusa Willd, Scutellaria barbata D. Don, herb pair, hepatocellular carcinoma | | --- | | Introduction
Primary hepatic cancer (PHC) is one of the most common malignant tumors in China, ranking the second in mortality among domestic malignant tumors. Its predominant pathological subtype is hepatocellular carcinoma (HCC), thus, PHC mentioned in this study specifically refers to hepatocellular carcinoma, hereinafter abbreviated as HCC.1 According to global cancer statistics, HCC is the sixth most common cancer and the third leading cause of cancer-related deaths worldwide, with nearly half of newly diagnosed cases each year occurring in China, which severely impairs people’s life and health.2 At present, clinical treatments for HCC in China mainly include Western medical approaches such as surgery, systemic chemotherapy, transcatheter arterial chemoembolization, and targeted therapy. However, their therapeutic efficacy still fails to meet the clinical needs of HCC patients, thus an urgent need for novel and effective therapeutic strategies as well as safe and efficient complementary treatment modalities. In TCM, HCC arises from the internal accumulation of turbid toxins, qi stagnation and blood stasis, and obstruction of the collaterals, leading to th

FAQs

Why is HCC a major focus in this review?

HCC is described as the dominant pathological subtype of primary hepatic cancer and is characterized as one of the most common malignancies with substantial worldwide mortality impact, including high incidence in China.

What therapeutic effects are attributed to the Hedyotis diffusa–Scutellaria barbata herb pair?

The review explains that existing research supports anti-HCC efficacy through modulation of apoptosis, proliferation, angiogenesis, and immune responses, with even more pronounced effects from combined or newly generated components after compatibility.

What evidence gap does the review address for the herb pair combination?

It states that to verify the pharmacological activity of the combined herb pair, further in vitro and in vivo model studies are necessary, and the review consolidates current evidence to guide ongoing research.

Sep 22, 2026

Upload by Mabel